Seabed-origin oil spills pose distinct challenges in marine pollution management due to their complex transport dynamics and ...

BOSTON — Cannabis regulators have ordered one of the state’s independent testing labs to suspend operations, alleging a “pattern of failing to accurately report” marijuana test results and ...

Fecal microbiota transplants are only FDA-approved for treating recurrent C. diff infections right now, but they may be part of the UC treatment mix in the future after more research is done.

A biotech company sold over 500,000 AI-powered health testing kits. Two C-suite leaders share how they kept science at the center.

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence ...

This treatment could benefit many different kinds of patients, but doctors will first need to address its unintended consequences.

Under the agreement reached by Brown County and C. Reiss, the company that owns the coal piles, a new port will need to be engineered and built on the former Pulliam Power Plant property to ...

In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader with a solution for itchy insect bites.

Enhancing variant interpretation in hereditary cancer testing with RNA analysis from residual blood samples.. If you have the appropriate software installed, you can download article citation data to ...

Delmarva hospitals' safety grades improved in spring 2025, with five A's, one B, and three C's. Explore what these scores say about the quality of care on Delmarva and how ...

Statsig has raised $100M in Series C funding at a $1.1B valuation to expand its platform for A/B testing, analytics, and feature management as AI transforms product development.

SAN DIEGO — Administration of Rebyota by colonoscopy appears safe and effective among adults with recurrent Clostridioides difficile infection, according to results from the CDI-SCOPE trial ...